| Tumor-infiltrating NY-ESO-1–specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer J Matsuzaki, S Gnjatic, P Mhawech-Fauceglia, A Beck, A Miller, T Tsuji, ... Proceedings of the National Academy of Sciences 107 (17), 7875-7880, 2010 | 983 | 2010 |
| Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints ME Mikucki, DT Fisher, J Matsuzaki, JJ Skitzki, NB Gaulin, JB Muhitch, ... Nature communications 6 (1), 7458, 2015 | 455 | 2015 |
| Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer Y Miyahara, K Odunsi, W Chen, G Peng, J Matsuzaki, RF Wang Proceedings of the National Academy of Sciences 105 (40), 15505-15510, 2008 | 406 | 2008 |
| LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model RY Huang, C Eppolito, S Lele, P Shrikant, J Matsuzaki, K Odunsi Oncotarget 6 (29), 27359, 2015 | 313 | 2015 |
| Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer K Odunsi, F Qian, J Matsuzaki, P Mhawech-Fauceglia, C Andrews, ... Proceedings of the National Academy of Sciences 104 (31), 12837-12842, 2007 | 310 | 2007 |
| Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients K Odunsi, J Matsuzaki, J Karbach, A Neumann, P Mhawech-Fauceglia, ... Proceedings of the National Academy of Sciences 109 (15), 5797-5802, 2012 | 211 | 2012 |
| Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer K Odunsi, J Matsuzaki, SR James, P Mhawech-Fauceglia, T Tsuji, A Miller, ... Cancer immunology research 2 (1), 37-49, 2014 | 189 | 2014 |
| CXCR3+ T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity N Redjimi, C Raffin, I Raimbaud, P Pignon, J Matsuzaki, K Odunsi, ... Cancer research 72 (17), 4351-4360, 2012 | 171 | 2012 |
| Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2, 3-dioxygenase–mediated arrest of T-cell proliferation in human epithelial … F Qian, J Villella, PK Wallace, P Mhawech-Fauceglia, JD Tario Jr, ... Cancer research 69 (13), 5498-5504, 2009 | 164 | 2009 |
| Generation of tumor-specific, HLA class I–restricted human Th1 and Tc1 cells by cell engineering with tumor peptide–specific T-cell receptor genes T Tsuji, M Yasukawa, J Matsuzaki, T Ohkuri, K Chamoto, D Wakita, ... Blood 106 (2), 470-476, 2005 | 137 | 2005 |
| Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity T Tsuji, J Matsuzaki, MP Kelly, V Ramakrishna, L Vitale, LZ He, T Keler, ... The Journal of Immunology 186 (2), 1218-1227, 2011 | 136 | 2011 |
| Expression and immune responses to MAGE antigens predict survival in epithelial ovarian cancer S Daudi, KH Eng, P Mhawech-Fauceglia, C Morrison, A Miliotto, A Beck, ... PloS one 9 (8), e104099, 2014 | 113 | 2014 |
| Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment KL Singel, TR Emmons, ANMNH Khan, PC Mayor, S Shen, JT Wong, ... JCI insight 4 (5), 2019 | 110 | 2019 |
| STAT6-mediated signaling in Th2-dependent allergic asthma: critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct … A Hoshino, T Tsuji, J Matsuzaki, T Jinushi, S Ashino, T Teramura, ... International immunology 16 (10), 1497-1505, 2004 | 110 | 2004 |
| Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity I Imazeki, J Matsuzaki, K Tsuji, T Nishimura Biomedical Research 27 (1), 1-9, 2006 | 109 | 2006 |
| Inflammatory responses to lipopolysaccharide are suppressed in 40% energy-restricted mice J Matsuzaki, M Kuwamura, R Yamaji, H Inui, Y Nakano The Journal of nutrition 131 (8), 2139-2144, 2001 | 105 | 2001 |
| Immunomodulatory action of SGI-110, a hypomethylating agent, in acute myeloid leukemia cells and xenografts P Srivastava, BE Paluch, J Matsuzaki, SR James, G Collamat-Lai, ... Leukemia research 38 (11), 1332-1341, 2014 | 98 | 2014 |
| Direct tumor recognition by a human CD4+ T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses J Matsuzaki, T Tsuji, IF Luescher, H Shiku, J Mineno, S Okamoto, LJ Old, ... Scientific reports 5 (1), 14896, 2015 | 97 | 2015 |
| Successful elimination of memory-type CD8+ T cell subsets by the administration of anti-Gr-1 monoclonal antibody in vivo J Matsuzaki, T Tsuji, K Chamoto, T Takeshima, F Sendo, T Nishimura Cellular immunology 224 (2), 98-105, 2003 | 92 | 2003 |
| NY-ESO-1 vaccination in combination with decitabine induces antigen-specific T-lymphocyte responses in patients with myelodysplastic syndrome EA Griffiths, P Srivastava, J Matsuzaki, Z Brumberger, ES Wang, J Kocent, ... Clinical Cancer Research 24 (5), 1019-1029, 2018 | 91 | 2018 |
